Year archive

EXACT Therapeutics AS — 2023 filings

All 47 regulatory filings released by EXACT Therapeutics AS (EXTX) in 2023, sourced directly from the official regulator.

47 Filings

2023 Period

2023 filings (47)

Filing	Released	Lang
EXACT Therapeutics AS – Share capital increase registered. Correction. Share Issue/Capital Change	2023-12-20	English
EXACT Therapeutics AS – Share capital increase registered Share Issue/Capital Change	2023-12-20	English
EXACT Therapeutics presenting at DNB Nordic Healthcare conference December 14 Regulatory Filings	2023-12-14	English
EXACT Therapeutics AS: Primary insider notices Director's Dealing	2023-12-01	English
EXACT Therapeutics AS: Primary insider notices Director's Dealing	2023-12-01	English
EXACT Therapeutics AS: Primary insider notices Director's Dealing	2023-12-01	English
EXACT Therapeutics AS: Primary insider notices Director's Dealing	2023-12-01	English
EXACT Therapeutics AS: Primary insider notices Director's Dealing	2023-12-01	English
EXACT Therapeutics AS: Primary insider notices Director's Dealing	2023-12-01	English
EXACT Therapeutics AS: Primary insider notices Director's Dealing	2023-12-01	English
EXACT Therapeutics AS: Primary insider notices Director's Dealing	2023-12-01	English
EXACT Therapeutics AS: Primary insider notices Director's Dealing	2023-12-01	English
EXACT Therapeutics AS: Private placement successfully placed Director's Dealing	2023-11-30	Norwegian
EXACT Therapeutics AS: Private placement successfully placed Capital/Financing Update	2023-11-30	English
EXACT Therapeutics AS: Contemplated Private Placement Capital/Financing Update	2023-11-30	English
EXACT Therapeutics receives regulatory approval to start recruitment of patients at Oslo University hospital Regulatory Filings	2023-10-31	English
EXACT Therapeutics AS – Issuance of share options Director's Dealing	2023-10-16	Norwegian
EXACT Therapeutics AS – Issuance of share options Remuneration Information	2023-10-16	English
EXACT Therapeutics CEO Dr Per Walday to participate in international Drug Delivery panel Regulatory Filings	2023-10-12	English
EXACT Therapeutics announces first half 2023 interim results Interim / Quarterly Report H1 2023	2023-09-28	English
EXACT Therapeutics announces first half 2023 interim results Investor Presentation	2023-09-28	English
EXACT Therapeutics announces first half 2023 interim results Report Publication Announcement	2023-09-28	English
EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development Board/Management Information	2023-09-27	English
EXACT Therapeutics announces positive clinical results from the ACTIVATE Phase I dose escalation Regulatory Filings	2023-09-26	English
EXACT Therapeutics announces positive clinical results from the ACTIVATE Phase I dose escalation Earnings Release Q3 2023	2023-09-26	English
Invitation to first half results 2023 presentation of EXACT Therapeutics AS Report Publication Announcement	2023-09-19	English
Financial calendar Report Publication Announcement	2023-09-13	English
EXACT Therapeutics and Cordance Medical Announce Strategic Partnership to Revolutionize Drug Delivery to the Brain Regulatory Filings	2023-09-06	English
EXACT Therapeutics and Cordance Medical Announce Strategic Partnership to Revolutionize Drug Delivery to the Brain Regulatory Filings	2023-09-06	English
EXACT Therapeutics completed the dose escalation part of ACTIVATE study Regulatory Filings	2023-08-07	English
EXACT Therapeutics receives regulatory approval to start the dose expansion part of ACTIVATE study Regulatory Filings	2023-07-31	English
EXACT Therapeutics minutes from Annual General Meeting June 9, 2023 AGM Information	2023-06-09	English
EXACT Therapeutics minutes from Annual General Meeting June 9, 2023 AGM Information	2023-06-09	English
EXACT Therapeutics AS - Notice of Annual General Meeting 2023 AGM Information	2023-05-31	Norwegian
EXACT Therapeutics AS - Notice of Annual General Meeting 2023 AGM Information	2023-05-31	English
EXACT Therapeutics Announces Granted Patent in United Kingdom for Acoustic Cluster Therapy (ACT®) Legal Proceedings Report	2023-05-30	English
EXACT Therapeutics Announces Granted Patent in United Kingdom for Acoustic Cluster Therapy (ACT®) Regulatory Filings	2023-05-30	English
EXACT Therapeutics AS announces the publication of the 2022 Annual Report Annual Report FY 2022	2023-04-21	English
EXACT Therapeutics AS announces the publication of the 2022 Annual Report Report Publication Announcement	2023-04-21	English
EXACT Therapeutics presents encouraging clinical case report data at Science & Technology Event Earnings Release Q1 2023	2023-03-28	English
EXACT Therapeutics presents encouraging clinical case report data at Science & Technology Event Investor Presentation	2023-03-28	English
Exact Therapeutics receives regulatory approval to reopen the ACTIVATE clinical trial Regulatory Filings	2023-02-02	English
Exact Therapeutics receives regulatory approval to reopen the ACTIVATE clinical trial Legal Proceedings Report	2023-02-02	English
Financial calendar Report Publication Announcement	2023-01-13	English
EXACT Therapeutics AS – Mandatory notification of trade by primary insiders Director's Dealing	2023-01-04	English
EXACT Therapeutics AS – Mandatory notification of trade by primary insiders Director's Dealing	2023-01-04	English
EXACT Therapeutics AS – Issuance of share options Share Issue/Capital Change	2023-01-03	English